Brief: Guard Therapeutics Receives IND Approval From FDA For RMC-035

Disruptive Pharma AB (publ)

10/10/2022 07:29

Oct 10 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * RECEIVES IND APPROVAL FROM FDA FOR RMC-035
    * U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS GRANTED CO'S
INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR INVESTIGATIONAL
DRUG RMC-035 (ROSGARD)
    * APPROVAL ENABLES EXPANSION OF CLINICAL DEVELOPMENT PROGRAM
FOR
RMC-035 TO US, INCLUDING ONGOING GLOBAL AND PLACEBO-CONTROLLED
PHASE 2 STUDY AKITA IN CARDIAC SURGERY

Source text for Eikon:  ID:nMFN8SFnTV 
Further company coverage:  GUARD.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))